Rockefeller University Scientists Find Tuberculosis Mutation’s ‘Weak Point
Researchers at the Rockefeller University and the Salk Institute have identified biological mechanisms that turn drug resistance into a vulnerability for pathogens and cancer cells. By exploiting the evolutionary trade-offs inherent in bacterial mutations and cancer cell diversity, scientists aim to develop combination therapies that effectively trap these threats in a state of increased susceptibility … Read more